Author:
Liu Ming,Zhang Weiyi,Tang Wei,Wang Yanjuan,Zhao Xingzeng,Wang Xiangyun,Qi Xin,Li Jing
Publisher
Springer Science and Business Media LLC
Reference31 articles.
1. Faneyte IF, Kristel PMP, Maliepaard M, Scheffer GL, Scheper RJ, Schellens JHM, et al. Expression of the breast cancer resistance protein in breast cancer. Clin Cancer Res. 2002;8(4):1068–74.
2. Vasconcelos FC, Cavalcanti GB, Silva KL, Ed M, Kwee JK, Rumjanek VM, et al. Contrasting features of MDR phenotype in leukemias by using two fluorochromes: implications for clinical practice. Leuk Res. 2007;31(4):445–54. doi: 10.1016/j.leukres.2006.07.016 .
3. Legrand O, Simonin G, Beauchamp-Nicoud A, Zittoun R, Marie J-P. Simultaneous activity of MRP1 and Pgp is correlated with in vitro resistance to daunorubicin and with in vivo resistance in adult acute myeloid leukemia, vol. 3. 1999.
4. Sotiropoulou PA, Christodoulou MS, Silvani A, Herold-Mende C, Passarella D. Chemical approaches to targeting drug resistance in cancer stem cells. Drug Discov Today. 2014;19(10):1547–62. http://dx.doi.org/10.1016/j.drudis.2014.05.002 .
5. Mannello F. Understanding breast cancer stem cell heterogeneity: time to move on to a new research paradigm. BMC Med. 2013;11(1):169.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献